Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Pradier

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Heliyon|February 23, 2017
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND)Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
Heliyon|April 4, 2017
Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohortMira Hleyhel, Aurélien Belot, Anne Marie Bouvier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
Plos One|July 23, 2015
Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 CohortSylvie Lang, Jean-Marc Lacombe, Murielle Mary-Krause, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2014
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strainsVéronique Blanc, Véronique Leflon-Guibout, Jorge Blanco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyLeah Shepherd, Lene Ryom, Matthew Law, et al.
AIDS (London, England)|May 31, 2018
Associations between serum albumin and serious non-AIDS events among people living with HIVAndreas Ronit, Camilla I Hatleberg, Lene Ryom, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Heliyon|February 23, 2017
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND)Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
Heliyon|April 4, 2017
Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohortMira Hleyhel, Aurélien Belot, Anne Marie Bouvier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
Plos One|July 23, 2015
Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 CohortSylvie Lang, Jean-Marc Lacombe, Murielle Mary-Krause, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2014
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strainsVéronique Blanc, Véronique Leflon-Guibout, Jorge Blanco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyLeah Shepherd, Lene Ryom, Matthew Law, et al.
AIDS (London, England)|May 31, 2018
Associations between serum albumin and serious non-AIDS events among people living with HIVAndreas Ronit, Camilla I Hatleberg, Lene Ryom, et al.
Pageof 17